Jobu Hospital for Respiratory Diseases, Gunma, Japan.
Tohkai Research Institute for Pollinosis, Shizuoka, Japan.
Allergol Int. 2020 Jul;69(3):387-404. doi: 10.1016/j.alit.2020.03.010. Epub 2020 May 27.
Occupational allergic diseases are likely to worsen or become intractable as a result of continuous exposure to high concentrations of causative allergens. These are socioeconomically important diseases that can lead to work interruptions for patients and potentially job loss. We published the first guideline for managing occupational allergic diseases in Japan. The original document was published in Japanese in 2013, and the following year (2014) it was published in English. This guideline consists of six chapters about occupational asthma, occupational allergic rhinitis, occupational skin diseases, hypersensitivity pneumonitis, occupational anaphylaxis shock, and the legal aspects of these diseases. Providing general doctors with the knowledge to make evidence-based diagnoses and to understand the occupational allergic disease treatment policies, was a breakthrough in allergic disease treatment. Due to the discovery of new occupational allergens and the accumulation of additional evidence, we published a revised version of our original article in 2016, and it was published in English in 2017. In addition to including new knowledge of allergens and evidence, the 2016 revision contains a "Flowchart to Diagnosis" for the convenience of general doctors. We report the essence of the revised guidelines in this paper.
职业性过敏性疾病由于持续暴露于高浓度的致病过敏原而可能恶化或变得难以治疗。这些疾病在社会经济学上很重要,可导致患者工作中断,并可能导致失业。我们在日本发布了第一份职业性过敏性疾病管理指南。原始文件于 2013 年以日文出版,次年(2014 年)以英文出版。该指南由六个章节组成,内容涉及职业性哮喘、职业性过敏性鼻炎、职业性皮肤病、过敏性肺炎、职业性过敏休克和这些疾病的法律方面。为一般医生提供基于证据的诊断知识,并了解职业性过敏性疾病的治疗政策,这是过敏疾病治疗的一个突破。由于新的职业性过敏原的发现和更多证据的积累,我们在 2016 年发布了原始文章的修订版,并于 2017 年以英文出版。除了包含过敏原和证据的新知识外,2016 年的修订版还包含了一个“诊断流程图”,方便一般医生使用。我们在本文中报告了修订指南的要点。